Applied Aerospace & Defense has entered a sharp downward spiral this week, with short sellers aggressively adding positions even as the stock trades nearly a third below its recent highs — the core tension being whether bears are right to press or overextended into a name where the Street still sees meaningful upside.
The short interest picture is the week's standout. Shares short have risen 67.5% over the past week, jumping from roughly 1.32 million to just under 2 million by August 27. That acceleration is striking relative to the stock's broader trajectory: SI was actually trending lower through early August before reversing hard this week. The ORTEX short score has followed — climbing from 33.6 on August 17 to 39.3 now, its highest reading in the available history. That said, the borrow market itself doesn't look strained. Availability is running at 638% — well above the 52-week low of 138% — meaning there are far more shares available to borrow than currently borrowed. Cost to borrow has also eased sharply, now around 1.5% versus 4.6% in mid-July. That cost compression tells an important story: the short side has grown quickly, but it is not a crowded or expensive trade. Bears are building into a falling stock with plenty of room to add more.
Options traders are leaning the opposite way. The put/call ratio is running at 0.76, about one standard deviation below its 20-day average of 0.82, and well beneath the 52-week high of 1.01 hit in late July. That suggests call activity is outpacing puts — a relative vote of confidence, or at minimum, a bet that the decline has been overdone. The divergence between a rising short book and declining PCR is the week's central contradiction: short sellers are pressing the downside while options participants are fading the move.
Analyst coverage is still fresh from the IPO era, with the stock having attracted initiations from BofA, Morgan Stanley, RBC, Stifel, and Baird in late June. BofA trimmed its target modestly to $23 from $24 on August 14, maintaining its Buy rating, while Morgan Stanley nudged its Equal-Weight target up by a dollar to $24. The mean target across the group is $25.14 — implying roughly 89% upside from the current $13.30 close. That gap is unusually wide for a stock with this degree of analyst coverage depth, and it reflects how severely the stock has de-rated from its IPO pricing levels. Valuation corroborates the stress: the P/E ratio is deeply negative at -159.9, worsening sharply over 30 days, while EV/EBITDA has held relatively stable around 18.2x — suggesting the earnings line, not enterprise value, is where the pressure is concentrated.
The institutional picture is telling. AA&D Holdings, LP controls 73.5% of shares — a commanding lock-up that severely constrains the actual float. The remaining institutional buyers that reported at June 30 were all building new positions, including AllianceBernstein, Temasek, MFS, Baron Capital, T. Rowe Price, and BlackRock. That concentration of fresh institutional buying in Q2 against a stock that has since lost 29% in a month suggests many of these holders are sitting on losses and the question of whether they add, hold, or trim at these levels will shape near-term supply dynamics.
Insiders bought at the IPO price of $20 in early June — the CFO put in $500,000, a director matched that, and two others added smaller amounts. With the stock now at $13.30, those purchases are all underwater by roughly a third. No follow-on buying has been reported since. The next earnings event is flagged for November 12, and the most recent print on August 12 saw the stock fall 8.7% the next day and 16.1% over the following five days — the clearest data point available on how this market reacts when the numbers disappoint.
What to watch next: whether the short-building pace of this week continues into next, whether any of the June-30 institutional buyers disclose follow-on activity, and how the stock behaves into November's earnings given the August print set a steep bar for downside reactions.
See the live data behind this article on ORTEX.
Open AADX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
